Site Search
Professionals 5 results
Capabilities 7 results
Practice Area
Winston & Strawn represents both private investment fund managers and institutional investors in the full range of legal and market practice issues involved in establishing, managing, and investing in private investment vehicles. By representing both managers and institutional investors, our attorneys have a unique perspective on the market drawing from in-depth experience and state-of-the-art knowledge of legal issues, deal terms, and market trends.
Practice Area
Addressing a crisis in today’s climate requires both swift action and careful consideration of all potential risks. Winston & Strawn is a trusted business adviser to clients facing complex, fast-moving, high-profile crises.
Industry
Experience 1 result
Experience
|May 9, 2025
An Am Law LOTW Shout Out-Worthy Gold Medal Victory In $Jenner
Winston, led by partners Jeffrey Steinfeld, John Schreiber, and George Mastoris, secured full dismissal of a high-profile securities class action involving hundred of millions of dollars in $Jenner memecoin trades. Plaintiffs alleged securities fraud under federal and California laws. The team was recognized in Am Law’s Litigator of the Week column for the win.
Insights & News 105 results
Client Alert
|November 11, 2025
|3 Min Read
On October 6, 2025, California Governor Gavin Newsom signed Senate Bill 351 (SB 351 or the Bill) into law, codifying certain prohibitions on the corporate practice of medicine and the use of certain restrictive covenants in the ownership and management of physician and dental practices. SB 351 aims to ensure that clinical decisions are exclusively made by licensed healthcare providers.
Client Alert
|September 22, 2025
|1 Min Read
Interest Rates Fall for SBICs: September 2025 Standard Debenture Pooling
The September 2025 pooling of Small Business Investment Company (SBIC) standard debentures was priced at 4.532%. This most recent semiannual pricing of SBIC standard debentures reflected a decrease from the rate set in March 2025 of 4.963%. This is the third consecutive semiannual pricing below 5.0% and is the second-lowest pricing since 2022.
Winston’s AI Top 10
|September 2025
|5 Min Read
Winston’s AI Monthly Recap - September 2025
Winston’s AI Top 10 summarizes the latest AI developments in the legal industry.
Other Results 4 results
Law Glossary
What Exclusivity Periods Are Associated with Biosimilars?
An applicant may not submit an aBLA until four years after the reference product is licensed by the FDA. (See BPCIA § 351(k).) Further, any biosimilar licenses “may not be made effective” until 12 years after the reference product was licensed. (See BPCIA § 351(l).)
Site Content
The Illinois Biometric Invasion of Privacy Act (BIPA), enacted in 2008, grants Illinois consumers the right to their own biometric data, such as fingerprints, retina or iris information, voiceprints, and DNA. Under the BIPA, private companies are prohibited from collecting biometric information unless (1) the person consents in writing and (2) the companies inform the person in writing of what data is being collected, for what purpose, and for how long. Besides the notice and consent requirement, the law also bans any company from selling or otherwise profiting from consumers’ biometrics.
Location
Serving one of the world’s largest economies for over 20 years, Winston & Strawn’s Los Angeles office is home to more than 100 lawyers and business professionals. Under the guidance of Office Managing Partner Angela Machala, our L.A. office thrives as a dynamic and tightly knit community with an inclusive culture in which its members from all backgrounds, experiences, and perspectives collaborate closely to support each other’s success and achieve their clients’ goals. Our L.A. lawyers—who are equally split between litigation and transactional work—advise 80+ Fortune 500 companies, which is a testament to the collaborative environment we’ve created to provide exceptional legal services.